Market Analysis and Insights: Global Metastatic Colorectal Cancer Surgery Market
Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body parts i.e. metastatic colorectal cancers are difficult to treat and have 11%-12% 5-year relative survival rate.
The global Metastatic Colorectal Cancer Surgery market size is projected to reach US$ million by 2030, from US$ million in 2022, at a CAGR of % during 2023-2030.
Treatment of metastatic colorectal cancer is multidisciplinary field involving early evaluation for resection of hepatic metastasis, metastasectomy and coordinated chemotherapy or radiation therapy. Primary factors driving growth of metastatic colorectal cancer treatment market are increasing prevalence of colorectal cancer across the globe, rapid innovation in personalized medicine and discovery of new targets for treatment of colorectal cancers.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Metastatic Colorectal Cancer Surgery market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Metastatic Colorectal Cancer Surgery market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Metastatic Colorectal Cancer Surgery market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Metastatic Colorectal Cancer Surgery market.
Global Metastatic Colorectal Cancer Surgery Scope and Market Size
Metastatic Colorectal Cancer Surgery market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Metastatic Colorectal Cancer Surgery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2030.
Segment by Type
Tumor Resection
Portal Vein Embolization
Segment by Application
Hospitals
Clinics
Cancer Research Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Sanofi
Roche
Eli Lilly
Pfizer
Novartis
Amgen
Taiho Oncology
Genentech
EMD Serono
Suzhou Zelgen Biopharmaceuticals
